Jason Rickard
Net Worth

Last updated:

What is Jason Rickard net worth?

The estimated net worth of Mr. Jason Rickard is at least $7,478,105 as of 28 Feb 2023. He owns shares worth $365,580 as insider, has earned $2,412,225 from insider trading and has received compensation worth at least $4,700,300 in Ironwood Pharmaceuticals, Inc..

What is the salary of Jason Rickard?

Mr. Jason Rickard salary is $940,060 per year as Chief Operating Officer & Senior Vice President of Operations in Ironwood Pharmaceuticals, Inc..

How old is Jason Rickard?

Mr. Jason Rickard is 54 years old, born in 1971.

What stocks does Jason Rickard currently own?

As insider, Mr. Jason Rickard owns shares in one company:

Company Title Shares Price per share Total value
Ironwood Pharmaceuticals, Inc. (IRWD) Chief Operating Officer & Senior Vice President of Operations 332,648 $1.1 $365,580

What does Ironwood Pharmaceuticals, Inc. do?

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.

IRWD logo
IRWD
Ironwood Pharmaceuticals, Inc.
$1.1

Jason Rickard insider trading

Ironwood Pharmaceuticals, Inc.

Mr. Jason Rickard has made 26 insider trades between 2020-2023, according to the Form 4 filled with the SEC. Most recently he sold 13,987 units of IRWD stock worth $158,193 on 28 Feb 2023.

The largest trade he's ever made was exercising 27,200 units of IRWD stock on 8 Aug 2022. As of 28 Feb 2023 he still owns at least 332,648 units of IRWD stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Class A Common Stock 13,987 $11.31 $158,193
Sale
Class A Common Stock 3,442 $11.31 $38,929
Sale
Class A Common Stock 13,438 $11.41 $153,328
Sale
Class A Common Stock 3,308 $11.41 $37,744
Sale
Class A Common Stock 27,000 $12.39 $334,530
Sale
Class A Common Stock 994 $11.77 $11,699
Option
Employee Stock Option (Right to Buy) 18,041 $11.65 $210,178
Option
Class A Common Stock 18,041 $11.65 $210,178
Sale
Class A Common Stock 18,041 $11.75 $211,982
Sale
Class A Common Stock 2,236 $11.56 $25,848
Sale
Class A Common Stock 27,200 $11.64 $316,608
Sale
Class A Common Stock 12,760 $11.5 $146,740
Sale
Class A Common Stock 777 $11.5 $8,936
Sale
Class A Common Stock 6,820 $10.77 $73,451
Sale
Class A Common Stock 11,057 $10.77 $119,084
Sale
Class A Common Stock 6,022 $10.77 $64,857
Sale
Class A Common Stock 3,150 $10.77 $33,926
Sale
Class A Common Stock 1,913 $10.77 $20,603
Sale
Class A Common Stock 27,000 $11.28 $304,560
Sale
Class A Common Stock 17,193 $11.58 $199,095
Sale
Class A Common Stock 680 $13.48 $9,166
Sale
Class A Common Stock 516 $12.25 $6,321
Sale
Class A Common Stock 13,651 $9.11 $124,361
Sale
Class A Common Stock 13,651 N/A N/A
Sale
Class A Common Stock 13,651 N/A N/A
Sale
Class A Common Stock 394 N/A N/A
Sale
Class A Common Stock 689 $10.14 $6,986
Sale
Class A Common Stock 510 $10.35 $5,279

Ironwood Pharmaceuticals key executives

Ironwood Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: